Safety and Effectiveness of Robotic-Assisted Remote Surgery for Breast Tumors

NCT07850323 | Completed

• 1 other identifier: SR-BC-202601
• Study Type: observational
• Target: 25
• Locations: 1 country
• Sites: 1

Brief Summary

This is a multicenter retrospective clinical study. The research aims to explore the safety and efficacy of robotic single-port thoracoscopic minimally invasive surgery for breast cancer patients. Patients receiving robotic single-port thoracoscopic surgery for breast tumors will be enrolled. We will collect perioperative indicators, postoperative complications and follow-up data to compare clinical outcomes, so as to provide evidence for the clinical application of remote robotic single-port thoracoscopic surgical technology in breast oncology.

Conditions

Breast Neoplasms

Keywords

Breast cancer; robotic surgery; single-port thoracoscopic surgery; minimally invasive operation; axillary lymph node dissection; retrospective clinical study

Outcome Measures

Primary Outcomes (2)

• Incidence of postoperative axillary complications

  Incidence of postoperative axillary complications

  30 days after surgery

• Incidence of postoperative axillary complications

  The incidence of postoperative axillary complications including seroma, hematoma, wound infection and upper limb lymphedema after axillary lymph node dissection.

  30 days after surgery

Study Arms (1)

Endoscopic-assisted axillary lymph node dissection group

Patients receiving endoscopic-assisted axillary lymph node dissection

Procedure: Robotic-assisted axillary lymph node dissection

Interventions

Robotic-assisted axillary lymph node dissection PROCEDURE

Robotic-assisted axillary lymph node dissection for breast cancer patients with positive lymph nodes

Endoscopic-assisted axillary lymph node dissection group

Eligibility Criteria

• Age: 18 Years - 85 Years
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Retrospective study of female patients with node-positive breast cancer receiving axillary lymph node dissection, comparing robotic-assisted versus endoscopic-assisted surgical approaches.

You may qualify if:

• Female patients aged 18-85 years;
• Pathologically confirmed node-positive breast cancer;
• Underwent robotic-assisted or endoscopic-assisted axillary lymph node dissection;
• Complete clinical and perioperative data available.

You may not qualify if:

• History of prior axillary surgery or radiotherapy;
• Distant metastatic disease;
• Severe cardiopulmonary, hepatic or renal dysfunction unsuitable for surgery;
• Incomplete clinical data. -

Sponsors & Collaborators

• Guangzhou Women and Children's Medical Center: lead

Study Sites (1)

Guangzhou Women and Children's Medical Center, Guangzhou Medical University

Guangzhou, Guangdong, 510623, China

Location

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by Site; Neoplasms; Breast Diseases; Skin Diseases; Skin and Connective Tissue Diseases

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Chief Physician, Department of Breast Surgery

Study Record Dates

• First Submitted: August 3, 2026
• First Posted: September 30, 2026
• Study Start: August 1, 2026
• Primary Completion: August 1, 2026
• Study Completion: August 1, 2026
• Last Updated: September 30, 2026

Record last verified: 2026-09

Locations

CN (1)